ResMed Inc.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $1.09B | $920.7M |
| Cost of Revenue | $436.9M | $366.9M |
| Gross Profit | $655.5M | $553.8M |
| Gross Margin | 60.0% | 60.1% |
| Operating Expenses | ||
| Research & Development | $75.2M | $63.1M |
| SG&A Expense | $328.9M | $289.9M |
| Operating Income | $240.4M | $190.3M |
| Operating Margin | 22.0% | 20.7% |
| Interest Expense | $2.7M | — |
| Pretax Income | $260.6M | $201.7M |
| Income Tax Expense | $70.5M | $55.2M |
| Net Income | $190.1M | $146.4M |
| Net Margin | 17.4% | 15.9% |
| EPS (Basic) | $1.26 | $0.97 |
| EPS (Diluted) | $1.23 | $0.95 |
| Shares Outstanding (Basic) | 150.9M | 151.3M |
| Shares Outstanding (Diluted) | 155.1M | 154.2M |
| Dividends Per Share | — | — |